Effect of umbilical cord mesenchymal stem cells on treatment of severe acute pancreatitis in rats

Cytotherapy

Volumn 15, Issue 2, 2013, Pages 154-162

  Yang, Bin ^a   Bai, Bin ^a   Liu, Chao Xu ^a   Wang, Shi Qi ^a   Jiang, Xue ^b   Zhu, Cai Lin ^a   Zhao, Qing Chuan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cell therapy; SAP; UCMSCs

Indexed keywords

AMYLASE; GAMMA INTERFERON; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CONTROLLED STUDY; DISEASE SEVERITY; DRY WEIGHT; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG PARENCHYMA; MALE; MESENCHYMAL STEM CELL; MORTALITY; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; SUSPENSION; TAIL; UMBILICAL CORD; UMBILICAL CORD MESENCHYMAL STEM CELL;

EID: 84875448702     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.11.007     Document Type: Article

References (21)

1. Frossard J-L, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008;371:143-52.
2. Pandol S, Saluja A, Imrie C, Banks P. Acute pancreatitis: bench to the bedside. Gastroenterology. 2007;132:1127-51 [erratum in Gastroenterology. 2007;133(3):1056].
3. Hayden P, Wyncoll D. Severe acute pancreatitis. Curr Anaesth Crit Care. 2008;19:1-7.
4. Lankisch PG, Lerch MM. Pharmacological prevention and treatment of acute pancreatitis: where are we now? Dig Dis. 2006;24:148-59.
5. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med. 2008;59:311-25.
6. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923-40.
7. Najar M, Rouas R, Raicevic G, et al. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy. 2009;11:570-83.
8. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2011;6:457-78.
9. Wittel UA, Wiech T, Chakraborty S, et al. Taurocholateinduced pancreatitis: a model of severe necrotizing pancreatitis in mice. Pancreas. 2008;36:-9-21.
10. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology. 1995;108:1917-22.
11. Pasparakis M, Courtois G, Hafner M, et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 2002;417:861-6.
12. Jung KH, Shin HP, Lee S, et al. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int. 2009;29:898-909.
13. Moodley Y, Atienza D, Manuelpillai U, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009;175: 303-13.
14. Schneider G, Saur D. Mesenchymal stem cells: therapeutic potential for acute pancreatitis. Gastroenterology. 2011;140: 779-82.
15. Marrache F, Pendyala S, Bhagat G, Betz KS, Song Z, Wang TC. Role of bone marrow-derived cells in experimental chronic pancreatitis. Gut. 2008;57:1113-20.
16. Jung KH, Song SU, Yi T, et al. Human bone marrow derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology. 2011;140: 998-1008.
17. Theise ND, Henegariu O, Grove J, et al. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol. 2002;30: 1333-8.
18. Chu PP, Bari S, Fan X, et al. Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion. Cytotherapy. 2012;14:1064-79.
19. Malmstrom ML, Hansen MB, Andersen AM, et al. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas. 2012;41:271-7.
20. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175:76-83.
21. Johnson CD, Kingsnorth AN, Imrie CW, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut. 2001;48:62-9.